FDA NDC Directory · JSON-LD · Markdown

ZONISADE

NDC 52652-8001 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameZONISAMIDE
Labeler / ManufacturerAzurity Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214273
Dosage form / routeSUSPENSION · ORAL
Active ingredientsZONISAMIDE (100 mg/5mL)
Marketing started20220715
Package count1

External sources

Source: openFDA. Public-domain (CC0).